Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles

European Journal of Medicinal Chemistry
2008.0

Abstract

The aim of this study was to investigate 4,5-diaryl isoselenazoles as multiple target non-steroidal anti-inflammatory drugs (MTNSAIDs) which can intervene into the inflammatory processes via different mechanisms of action creating a new class of compounds. Here we describe the synthesis of COX/LOX inhibitors which additionally reduce the level of reactive oxygen species, such as hydroxyl radicals which are well known for supporting inflammation processes in Parkinson's disease, Alzheimer's disease and rheumatoid arthritis.

Knowledge Graph

Similar Paper

Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles
European Journal of Medicinal Chemistry 2008.0
Diaryl-dithiolanes and -isothiazoles: COX-1/COX-2 and 5-LOX-inhibitory, OH scavenging and anti-adhesive activities
Bioorganic & Medicinal Chemistry 2009.0
4-Aryl/cycloalkyl-5-phenyloxazole derivatives as selective COX-2 inhibitors
Bioorganic & Medicinal Chemistry Letters 2002.0
Synthesis and biological evaluation of isoxazolo[4,5-d]pyridazin-4-(5H)-one analogues as potent anti-inflammatory agents
Bioorganic & Medicinal Chemistry 2012.0
Benzoselenazolinone Derivatives Designed To Be Glutathione Peroxidase Mimetics Feature Inhibition of Cyclooxygenase/5-Lipoxygenase Pathways and Anti-inflammatory Activity
Journal of Medicinal Chemistry 1994.0
Synthetically-tailored and nature-derived dual COX-2/5-LOX inhibitors: Structural aspects and SAR
European Journal of Medicinal Chemistry 2021.0
Design, synthesis, and biological evaluation of substituted 2-alkylthio-1,5-diarylimidazoles as selective COX-2 inhibitors
Bioorganic & Medicinal Chemistry 2007.0
2-(2-Arylphenyl)benzoxazole As a Novel Anti-Inflammatory Scaffold: Synthesis and Biological Evaluation
ACS Medicinal Chemistry Letters 2014.0
Antiinflammatory 4,5-diarylimidazoles as selective cyclooxygenase inhibitors
Bioorganic & Medicinal Chemistry Letters 1998.0
Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents
Bioorganic & Medicinal Chemistry Letters 2012.0